INTERLEUKIN GENETICS INC: 10-Q filed 2012-11-14

Name: INTERLEUKIN GENETICS INC: 10-Q filed 2012-11-14
Creator: INTERLEUKIN GENETICS INC

What INTERLEUKIN GENETICS INC reported in its quarterly report filed 2012-11-14 (fiscal Q3 2012): 36 published measures, 101 facts as tagged in accession 0001144204-12-062526.

This filing

Form: 10-Q (quarterly report)
Filed: 2012-11-14
Fiscal period: fiscal Q3 2012
Accession: 0001144204-12-062526 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All INTERLEUKIN GENETICS INC filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2012-09-30	3,506,707	USD
At 2011-12-31	2,953,517	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2012-09-30	-12,455,434	USD
At 2011-12-31	-11,423,231	USD
At 2011-09-30	-10,055,362	USD
At 2010-12-31	-6,658,096	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2012-09-30	2,489,156	USD
At 2011-12-31	1,728,222	USD
At 2011-09-30	1,014,764	USD
At 2010-12-31	3,999,029	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	-1,286,224	USD	92
2012-01-01 to 2012-09-30	-3,930,765	USD	274
2011-07-01 to 2011-09-30	-1,134,542	USD	92
2011-01-01 to 2011-09-30	-3,602,520	USD	273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2012-01-01 to 2012-09-30	-3,278,008	USD	274
2011-01-01 to 2011-09-30	-3,206,581	USD	273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2012-01-01 to 2012-09-30	5,000	USD	274
2011-01-01 to 2011-09-30	3,258	USD	273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	420,011	USD	92
2012-01-01 to 2012-09-30	1,897,331	USD	274
2011-07-01 to 2011-09-30	765,416	USD	92
2011-01-01 to 2011-09-30	2,281,765	USD	273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2012-01-01 to 2012-09-30	4,043,942	USD	274
2011-01-01 to 2011-09-30	25,574	USD	273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2012-01-01 to 2012-09-30	-5,000	USD	274
2011-01-01 to 2011-09-30	196,742	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2012-09-30	-106,507,346	USD
At 2011-12-31	-102,576,581	USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Unit	Days
2012-07-01 to 2012-09-30	USD	92
2012-01-01 to 2012-09-30	USD	274
2011-07-01 to 2011-09-30	USD	92
2011-01-01 to 2011-09-30	USD	273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2012-09-30	155,301	USD
At 2011-12-31	289,011	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	74,745	USD	92
2012-01-01 to 2012-09-30	170,875	USD	274
2011-07-01 to 2011-09-30	48,713	USD	92
2011-01-01 to 2011-09-30	179,680	USD	273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	-1,170,585	USD	92
2012-01-01 to 2012-09-30	-3,596,799	USD	274
2011-07-01 to 2011-09-30	-1,045,462	USD	92
2011-01-01 to 2011-09-30	-3,503,108	USD	273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2012-09-30	2,885,410	USD
At 2011-12-31	2,111,921	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	117,276	USD	92
2012-01-01 to 2012-09-30	337,206	USD	274
2011-07-01 to 2011-09-30	90,110	USD	92
2011-01-01 to 2011-09-30	267,390	USD	273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2012-09-30	15,962,141	USD
At 2011-12-31	14,376,748	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2012-09-30	293,076	USD
At 2011-12-31	369,306	USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

Period	Value	Unit	Days
At 2012-09-30	427,995	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2012-09-30	57,334	USD
At 2011-12-31	55,892	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	1,319,166	USD	92
2012-01-01 to 2012-09-30	4,453,366	USD	274
2011-07-01 to 2011-09-30	1,440,138	USD	92
2011-01-01 to 2011-09-30	4,618,080	USD	273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2012-09-30	64,545	USD
At 2011-12-31	107,758	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	148,581	USD	92
2012-01-01 to 2012-09-30	856,567	USD	274
2011-07-01 to 2011-09-30	394,676	USD	92
2011-01-01 to 2011-09-30	1,114,972	USD	273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	271,430	USD	92
2012-01-01 to 2012-09-30	1,040,764	USD	274
2011-07-01 to 2011-09-30	370,740	USD	92
2011-01-01 to 2011-09-30	1,166,793	USD	273

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	1,044,567	USD	92
2012-01-01 to 2012-09-30	3,357,327	USD	274
2011-07-01 to 2011-09-30	1,086,606	USD	92
2011-01-01 to 2011-09-30	3,542,203	USD	273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	245,736	USD	92
2012-01-01 to 2012-09-30	1,009,449	USD	274
2011-07-01 to 2011-09-30	324,669	USD	92
2011-01-01 to 2011-09-30	989,287	USD	273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2012-09-30	36,761,864	shares
At 2011-12-31	36,709,706	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2012-09-30	94,009,650	USD
At 2011-12-31	91,111,640	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2012-09-30	427,995	USD
At 2011-12-31	514,584	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2012-09-30	38,001	USD
At 2011-12-31	38,001	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2012-09-30	381,493	USD
At 2011-12-31	182,597	USD

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	28,863	USD	92
2012-01-01 to 2012-09-30	86,590	USD	274
2011-07-01 to 2011-09-30	28,863	USD	92
2011-01-01 to 2011-09-30	86,590	USD	273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	-115,639	USD	92
2012-01-01 to 2012-09-30	-333,966	USD	274
2011-07-01 to 2011-09-30	-89,080	USD	92
2011-01-01 to 2011-09-30	-257,778	USD	273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2012-01-01 to 2012-09-30	1,442	USD	274
2011-01-01 to 2011-09-30	39,407	USD	273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2012-01-01 to 2012-09-30	-43,213	USD	274
2011-01-01 to 2011-09-30	-42,315	USD	273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2012-01-01 to 2012-09-30	-76,230	USD	274
2011-01-01 to 2011-09-30	-126,558	USD	273

Inspect the source

Entity: INTERLEUKIN GENETICS INC / CIK 0001037649
Captured: 2026-09-22 19:37 UTC
SEC response SHA-256: a1dec64965ae0507fde1f8bdab94feeb924a2817b4582e8fe10de362809c5bbd

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001037649.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))